First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
====================================================================================================================================================================================

* Martin Wermke
* Tobias A W Holderried
* Jason John Luke
* Van K Morris
* Winfried H Alsdorf
* Katrin Wetzko
* Borje S Andersson
* Ignacio I Wistuba
* Edwin R Parra
* Mohammad B Hossain
* Sandra Grund-Gröschke
* Katrin Aslan
* Arun Satelli
* Anantha Marisetty
* Swapna Satam
* Mamta Kalra
* Jens Hukelmann
* M Alper Kursunel
* Karine Pozo
* Andreas Acs
* Linus Backert
* Melissa Baumeister
* Sebastian Bunk
* Claudia Wagner
* Oliver Schoor
* Ali S Mohamed
* Andrea Mayer-Mokler
* Norbert Hilf
* Delfi Krishna
* Steffen Walter
* Apostolia M Tsimberidou
* Cedrik M Britten